The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD
Introduction Treatment options for ADHD in adults consist of psycho-education, cognitive behavioral therapy (CBT), pharmacotherapy or a combination thereof. Current studies do not yet provide insights into the additive effects of CBT and pharmacotherapy regarding the quality of life in adults with...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2022-06-01
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822015644/type/journal_article |
| _version_ | 1797617065234792448 |
|---|---|
| author | R. Wettstein Y. Klabbers E. Romijn J. Nieuwveen H. Kroesen K. Wettstein G. Dumont |
| author_facet | R. Wettstein Y. Klabbers E. Romijn J. Nieuwveen H. Kroesen K. Wettstein G. Dumont |
| author_sort | R. Wettstein |
| collection | DOAJ |
| description |
Introduction
Treatment options for ADHD in adults consist of psycho-education, cognitive behavioral therapy (CBT), pharmacotherapy or a combination thereof. Current studies do not yet provide insights into the additive effects of CBT and pharmacotherapy regarding the quality of life in adults with ADHD.
Objectives
In this study, we investigated the effect of CBT combined with pharmacotherapy on the quality of life in adults with ADHD compared to pharmacotherapy alone.
Methods
In this multicenter prospective cohort study a total of 627 patients were included, 305 where included in the pharmacotherapy only group and 322 in de combination group (CBT and pharmacotherapy). The Adult ADHD Quality-of-Life scale (AAQoL) was conducted at baseline and at the end of treatment.
Results
No significant differences were found in gender or age between groups at baseline. The average improvement in the AAQoL total score in the pharmacotherapy group was 26.81(17.12) and in the combination group 25.45(16.33) and showed no significant difference (t(543) = 0.96, p = 0.34). At baseline the average total score in the pharmacotherapy group was 45.5(12.37) and 42.22(12.73) in the combination group (t(543)=2.86, p = 0.004). The average total score at the end of treatment in the pharmacotherapy and combination group was 72.31(12.99) and 67.67(12.45), respectively (t(543)=426, p <0.001).
Conclusions
To our knowledge, this is the first study to describe the value of CBT in addition to pharmacotherapy on the quality of life in adults with ADHD. Contrary to our expectations, there was no significant effect of CBT in addition to pharmacotherapy on the quality of life.
Disclosure
No significant relationships.
|
| first_indexed | 2024-03-11T07:50:32Z |
| format | Article |
| id | doaj.art-5dc8fa17ef1448c3a2b4f8c92bb319fc |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:50:32Z |
| publishDate | 2022-06-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-5dc8fa17ef1448c3a2b4f8c92bb319fc2023-11-17T05:06:53ZengCambridge University PressEuropean Psychiatry0924-93381778-35852022-06-0165S610S61110.1192/j.eurpsy.2022.1564The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHDR. Wettstein0Y. Klabbers1E. Romijn2J. Nieuwveen3H. Kroesen4K. Wettstein5G. Dumont6Amsterdam university medical center, Clinical Pharmacology And Pharmacy, Amsterdam, Netherlands ADHDcentraal, Research & Development, Nieuwegein, NetherlandsGGNet, Ivb, Warnsveld, NetherlandsADHDcentraal, Research & Development, Nieuwegein, NetherlandsADHDcentraal, Research & Development, Nieuwegein, NetherlandsADHDcentraal, Research & Development, Nieuwegein, NetherlandsADHDcentraal, Research & Development, Nieuwegein, NetherlandsAmsterdam university medical center, Clinical Pharmacology And Pharmacy, Amsterdam, Netherlands ADHDcentraal, Research & Development, Nieuwegein, Netherlands Introduction Treatment options for ADHD in adults consist of psycho-education, cognitive behavioral therapy (CBT), pharmacotherapy or a combination thereof. Current studies do not yet provide insights into the additive effects of CBT and pharmacotherapy regarding the quality of life in adults with ADHD. Objectives In this study, we investigated the effect of CBT combined with pharmacotherapy on the quality of life in adults with ADHD compared to pharmacotherapy alone. Methods In this multicenter prospective cohort study a total of 627 patients were included, 305 where included in the pharmacotherapy only group and 322 in de combination group (CBT and pharmacotherapy). The Adult ADHD Quality-of-Life scale (AAQoL) was conducted at baseline and at the end of treatment. Results No significant differences were found in gender or age between groups at baseline. The average improvement in the AAQoL total score in the pharmacotherapy group was 26.81(17.12) and in the combination group 25.45(16.33) and showed no significant difference (t(543) = 0.96, p = 0.34). At baseline the average total score in the pharmacotherapy group was 45.5(12.37) and 42.22(12.73) in the combination group (t(543)=2.86, p = 0.004). The average total score at the end of treatment in the pharmacotherapy and combination group was 72.31(12.99) and 67.67(12.45), respectively (t(543)=426, p <0.001). Conclusions To our knowledge, this is the first study to describe the value of CBT in addition to pharmacotherapy on the quality of life in adults with ADHD. Contrary to our expectations, there was no significant effect of CBT in addition to pharmacotherapy on the quality of life. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S0924933822015644/type/journal_articleCognitive behavioral therapyQuality of Lifeadultsadhd |
| spellingShingle | R. Wettstein Y. Klabbers E. Romijn J. Nieuwveen H. Kroesen K. Wettstein G. Dumont The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD European Psychiatry Cognitive behavioral therapy Quality of Life adults adhd |
| title | The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD |
| title_full | The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD |
| title_fullStr | The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD |
| title_full_unstemmed | The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD |
| title_short | The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD |
| title_sort | value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with adhd |
| topic | Cognitive behavioral therapy Quality of Life adults adhd |
| url | https://www.cambridge.org/core/product/identifier/S0924933822015644/type/journal_article |
| work_keys_str_mv | AT rwettstein thevalueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT yklabbers thevalueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT eromijn thevalueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT jnieuwveen thevalueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT hkroesen thevalueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT kwettstein thevalueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT gdumont thevalueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT rwettstein valueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT yklabbers valueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT eromijn valueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT jnieuwveen valueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT hkroesen valueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT kwettstein valueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd AT gdumont valueofcognitivebehavioraltherapyonqualityoflifeinadditiontopharmacotherapyinadultswithadhd |